Our Recommendations
- Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children (2022)
- Tuberculosis (TB) (2022)
- National Guidelines on Management of Tuberculosis in Children, 3rd ed. (2017)
- Tuberculose. Guide pratique à l’usage des médecins, infirmiers, techniciens de laboratoire et auxiliaires de santé (2022)
- WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support (2022)
New Publications
- Roadmap towards ending TB in children and adolescents, 3rd ed (2023)
- Child-friendly formulations for drug-resistant tuberculosis (2022)
- Tuberculose. Guide pratique à l’usage des médecins, infirmiers, techniciens de laboratoire et auxiliaires de santé (2022)
- Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries (2022)
- Rapid communication on updated guidance on the management of tuberculosis in children and adolescents (2021)
Filter
47
Featured
Recommendations
7
New Publications
6
Language
Document type
No document type
29
Guidelines
10
Fact sheets
4
Studies & Reports
2
Manuals
1
Strategic & Response Plan
1
Countries / Regions
Kenya
1
El Salvador
1
Africa
1
Germany
1
South–East Asia Region
1
India
1
Authors & Publishers
Publication Years
Category
TB
10
Pediatrics
8
Paediatrics
2
Policies & Guidelines HIV & TB
2
Under-5 nutrition
1
x MEDBOX Issue Brief & Annual Reports x
1
Toolboxes
The Roadmap towards ending TB among children and adolescents, third edition builds on the 2013 and 2018 versions. The 2023 version recognizes the progress made over the past five years and outlines priorities and key actions designed to accelerate progress towards the targets elaborated during the 2...
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
El agente etiológico de la tuberculosis es el Mycobacterium tuberculosis o bacilo de Koch. Se trata de un bacilo aerobio estricto, ácido-alcohol resistente, sin movilidad, de crecimiento lento y que se inactiva con rayos ultravioleta y temperaturas mayores de 60°C.
Tuberculosis (TB)
recommended
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p...
Clinical guideline for paediatric care of tuberculosis and TB-HIV co-infection
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Consensus -based guidelines for diagnosis, prevention and treatment of tuberculosis in children and adolescents
Accessed November 2017
Accessed November 2017
